A Phase I Trial For The Treatment Of Purine Analog-Refractory Chronic Lymphocytic Leukemia Using Autologous T Cells Genetically Targeted To The B Cell Specific Antigen Cd19

JOURNAL OF CLINICAL ONCOLOGY(2008)

引用 5|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要